FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Presidio Partners 2007, L.P.   2. Issuer Name and Ticker or Trading Symbol Neos Therapeutics, Inc. [NEOS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) ONE LETTERMAN DRIVE, BUILDING C, SUITE CM500 3. Date of Earliest Transaction (Month/Day/Year) 07/27/2015 (Street) SAN FRANCISCO, CA 94129 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/28/2015   C   406,250 A (1) 406,250 D   Common Stock 07/28/2015   C   677,622 A (1) 1,083,872 D   Common Stock 07/28/2015   C   162,500 A (2) 1,246,372 D   Common Stock 07/28/2015   C   10,416 A (1) 1,256,788 I by Presidio Partners 2007 (Parallel), L.P Common Stock 07/28/2015   C   17,374 A (1) 1,274,162 I by Presidio Partners 2007 (Parallel), L.P Common Stock 07/28/2015   C   4,166 A (2) 1,278,328 I by Presidio Partners 2007 (Parallel), L.P

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock	(1)	07/28/2015		C			975,000	(1)	(1)	Common Stock	406,250	(1)	0	D
Series C Preferred Stock	(1)	07/28/2015		C			1,626,294	(1)	(1)	Common Stock	677,622	(1)	0	D
Preferred Stock Warrant (Right to Buy)	(1)	07/27/2015		X			390,000	(3)	01/30/2018	Series C Preferred Stock	390,000	(3)	0	D
Series C Preferred Stock	(1)	07/28/2015		C			390,000	(1)	(1)	Common Stock	162,500	(1)	0	D
Series B Preferred Stock	(1)	07/28/2015		C			25,000	(1)	(1)	Common Stock	10,416	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Series C Preferred Stock	(1)	07/28/2015		C			41,700	(1)	(1)	Common Stock	17,374	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Preferred Stock Warrant (Right to Buy)	(3)	07/27/2015		X			10,000	(3)	01/30/2018	Series C Preferred Stock	10,000	(3)	0	I	By Presidio Partners 2007 (Parallel), L.P.
Series C Preferred Stock	(1)	07/28/2015		C			10,000	(1)	(1)	Common Stock	4,166	(1)	0	I	By Presidio Partners 2007 (Parallel), L.P.

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Presidio Partners 2007, L.P. ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Presidio Partners 2007 (Parallel), L.P. ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Presidio Partners 2007 GP, L.P. ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Collier David J ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Watson James F ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Presidio Partners 2007 GP, LLC ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Sohail Faysal A. ONE LETTERMAN DRIVE BUILDING C, SUITE CM500 SAN FRANCISCO, CA 94129		X

Signatures

PRESIDIO PARTNERS 2007, L.P. By: Presidio Partners 2007 GP, L.P., its General Partner By: Presidio Partners 2007 GP LLC, its General Partner /s/ David J. Collier, Manager		07/28/2015
**Signature of Reporting Person		Date
Presidio Partners 2007 (Parallel), L.P. By: /s/ David J. Collier, Manager		07/28/2015
**Signature of Reporting Person		Date
Presidio Partners 2007 GP, L.P. /s/ David J. Collier, Manager		07/28/2015
**Signature of Reporting Person		Date
/s/ David J. Collier		07/28/2015
**Signature of Reporting Person		Date
/s/ James F. Watson		07/28/2015
**Signature of Reporting Person		Date
Presidio Partners 2007 GP, LLC /s/ David J. Collier, Manager		07/28/2015
**Signature of Reporting Person		Date
/s/ Faysal A. Sohail		07/28/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each share of the Issuer's Series B preferred stock and Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B preferred stock and Series C preferred stock had no expiration date.
(2)	Based upon and including the number of shares of common stock listed in column 4 issued upon the automatic conversion of the underlying shares of Series C preferred stock in accordance with Footnote (1) above, such shares of Series C preferred stock issued in accordance with the warrant exercise set forth in Footnote (3) below.
(3)	The preferred stock warrant was exercised in full on July 27, 2015 for the number of underlying shares of Series C preferred stock. The shares of Series C preferred stock have no expiration date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.